Volume 122, Issue 7, Pages (June 2002)

Slides:



Advertisements
Similar presentations
Celiac disease–like abnormalities in a subgroup of patients with irritable bowel syndrome Ulrich Wahnschaffe, R. Ullrich, E.O. Riecken, J.D. Schulzke Gastroenterology.
Advertisements

Serum immunoglobulin a from patients with celiac disease inhibits human T84 intestinal crypt epithelial cell differentiation Tuula Halttunen, Markku Mäki.
Interleukin 15 mediates epithelial changes in celiac disease Luigi Maiuri, Carolina Ciacci, Salvatore Auricchio, Virginia Brown, Sonia Quaratino, Marco.
Volume 129, Issue 3, Pages (September 2005)
Current concepts of celiac disease pathogenesis
Alessio Fasano, Carlo Catassi  Gastroenterology 
Luise Westernberg, PhD, Véronique Schulten, PhD, Jason A
Volume 27, Issue 1, Pages (July 2007)
Volume 128, Issue 2, Pages (February 2005)
Identification of alloreactive T-cell epitopes on the Rhesus D protein
Overview and pathogenesis of celiac disease
Enzyme-modified wheat gliadin activates T cells in celiac disease
Volume 149, Issue 6, Pages e2 (November 2015)
Volume 154, Issue 4, Pages e6 (March 2018)
HLA-DPB1 Mismatching Results in the Generation of a Full Repertoire of HLA-DPB1- Specific CD4+ T Cell Responses Showing Immunogenicity of all HLA-DPB1.
Volume 131, Issue 2, Pages (August 2006)
IgA and IgM VH repertoires in human colon: Evidence for clonally expanded B cells that are widely disseminated  Wolfgang Holtmeier, Andreas Hennemann,
Turning Swords Into Plowshares: Transglutaminase to Detoxify Gluten
Ira J. Fox, Stephen C. Strom  Gastroenterology 
T-Cell Response to Gluten in Patients With HLA-DQ2
Tissue transglutaminase generates deamidated epitopes on gluten, increasing reactivity with hydrolyzed wheat protein–sensitized IgE  Ryosuke Nakamura,
Volume 124, Issue 4, Pages (April 2003)
Interleukin 15 mediates epithelial changes in celiac disease
Volume 114, Issue 1, Pages (January 1998)
Volume 133, Issue 3, Pages (September 2007)
Spreading and focusing of gluten epitopes in celiac disease
Proteomic Approaches to Cancer Biomarkers
Identification of a Coordinated CD8 and CD4 T Cell Response Directed Against Mismatched HLA Class I Causing Severe Acute Graft-versus-Host Disease  Avital.
Volume 27, Issue 1, Pages (July 2007)
Volume 122, Issue 2, Pages (February 2002)
Enzyme-modified wheat gliadin activates T cells in celiac disease
Mutated regions of nucleophosmin 1 elicit both CD4+ and CD8+ T-cell responses in patients with acute myeloid leukemia by Jochen Greiner, Yoko Ono, Susanne.
Ulrich Wahnschaffe, R. Ullrich, E.O. Riecken, J.D. Schulzke 
High prevalence of ST-78 infection-associated vancomycin-resistant Enterococcus faecium from hospitals in Asunción, Paraguay  M.A. Khan, J.B. Northwood,
Current concepts of celiac disease pathogenesis
Characterization of human memory CD4+ T-cell responses to the dog allergen Can f 4  Aino L. Rönkä, MD, Tuure T. Kinnunen, MD, PhD, Amélie Goudet, BSc,
Volume 123, Issue 3, Pages (September 2002)
Volume 37, Issue 4, Pages (October 2012)
Volume 128, Issue 2, Pages (February 2005)
Volume 120, Issue 4, Pages (March 2001)
Celiac Disease: From Pathogenesis to Novel Therapies
Volume 18, Issue 5, Pages (November 2015)
Naturally processed T cell–activating peptides of the major birch pollen allergen  Sonja Mutschlechner, PhD, Matthias Egger, PhD, Peter Briza, PhD, Michael.
Alessio Fasano, Carlo Catassi  Gastroenterology 
Volume 127, Issue 3, Pages (September 2004)
Volume 129, Issue 3, Pages (September 2005)
Volume 122, Issue 7, Pages (June 2002)
Volume 24, Issue 10, Pages (October 2016)
Characterization of the allergic T-cell response to Pru p 3, the nonspecific lipid transfer protein in peach  Véronique Schulten, MSc, Astrid Radakovics,
Volume 120, Issue 1, Pages (January 2001)
Volume 122, Issue 2, Pages (February 2002)
Celiac disease Journal of Allergy and Clinical Immunology
AGA technical review on celiac sprue
Volume 123, Issue 4, Pages (October 2002)
Volume 123, Issue 5, Pages (November 2002)
Celiac Disease: Caught Between a Rock and a Hard Place
Volume 153, Issue 3, Pages e4 (September 2017)
Volume 37, Issue 4, Pages (October 2012)
Peanut T-cell epitope discovery: Ara h 1
Antigen presentation of the immunodominant T-cell epitope of the major mugwort pollen allergen, Art v 1, is associated with the expression of HLA-DRB1∗01 
Identification of mouse AAV capsid-specific CD8+ T cell epitopes
Serum immunoglobulin a from patients with celiac disease inhibits human T84 intestinal crypt epithelial cell differentiation  Tuula Halttunen, Markku.
AGA technical review on osteoporosis in gastrointestinal diseases
Michelle Maria Pietzak  Gastroenterology 
Volume 129, Issue 3, Pages (September 2005)
Volume 133, Issue 3, Pages (September 2007)
Volume 125, Issue 4, Pages (October 2003)
Minor Histocompatibility Antigen DDX3Y Induces HLA-DQ5-Restricted T Cell Responses with Limited TCR-Vβ Usage Both In Vivo and In Vitro  David Laurin,
Gastrointestinal digestion of Bet v 1–homologous food allergens destroys their mediator- releasing, but not T cell–activating, capacity  Eva Maria Schimek,
Volume 115, Issue 4, Pages (October 1998)
Presentation transcript:

Volume 122, Issue 7, Pages 1729-1737 (June 2002) The gluten response in children with celiac disease is directed toward multiple gliadin and glutenin peptides  Willemijn Vader, Yvonne Kooy, Peter van Veelen, Arnoud de Ru, Diana Harris, Willemien Benckhuijsen, Salvador Peña, Luisa Mearin, Jan Wouter Drijfhout, Frits Koning  Gastroenterology  Volume 122, Issue 7, Pages 1729-1737 (June 2002) DOI: 10.1053/gast.2002.33606 Copyright © 2002 American Gastroenterological Association Terms and Conditions

Fig. 1 GLU-specific responses of T-cell lines from pediatric CD patients. GLU recognition by small intestinal T-cell lines generated after initial GLU challenge with (A) GLU and (B) with tTG-GLU. The T-cell lines were tested against the GLU (hatched symbols) and tTG-GLU (closed symbols) preparations. (B) Three T-cell lines isolated from small intestinal biopsies of HLA-DQ2+ controls are shown. Responses were considered positive when the GLU-specific stimulation was 3 times above background: SI ≥ 3. The T-cell lines that were used for cloning are underlined. *Tested against GLU only. Gastroenterology 2002 122, 1729-1737DOI: (10.1053/gast.2002.33606) Copyright © 2002 American Gastroenterological Association Terms and Conditions

Fig. 2 Identification of the GLIA epitope GLIA-α20. The TCC JB20 responded to 5 of 50 peptide-pools, each containing 5 tTG treated GLIA and/or GLT peptides. A single sequence was present in the stimulatory pools but not in nonstimulatory pools, e.g., pool 32. A newly synthesized version of this peptide, termed GLIA-α20, was recognized by the TCC. Cpm represents incorporated 3H-thymidine values (the negative control was 312 ± 324 cpm). Some peptides were synthesized with a mixture of 2 amino acids at particular amino acid position. This is indicated as follows: U= P + L; X= P + Q; Y= P + S; Z= P + R. Gastroenterology 2002 122, 1729-1737DOI: (10.1053/gast.2002.33606) Copyright © 2002 American Gastroenterological Association Terms and Conditions

Fig. 3 Mass spectral analysis of deamidation of the GLIA-γ30 epitope. (A) Predicted ion fragment masses of the GLIA-γ30 epitope based on amino acid sequence. (B) Observed fragments of the GLIA-γ30 epitope, b-ions are indicated according to panel A. (C) Observed fragments of the GLIA-γ30 epitope after deamidation by tTG. The mass difference between the b-ions 228 and 413 in panel B corresponds to the sequence GQ. This mass difference has increased 1 dalton in panel C (b-ions 228 and 414), which corresponds to the sequence GE and indicates a Q to E conversion at position 4. Similarly, the Q at position 10 is converted into an E by tTG treatment as indicated by the 2 dalton shift of the b10-ion from 1049 to 1051. Gastroenterology 2002 122, 1729-1737DOI: (10.1053/gast.2002.33606) Copyright © 2002 American Gastroenterological Association Terms and Conditions

Fig. 4 Recognition of the novel DQ2 epitopes. The effect of deamidation on recognition of the new GLU epitopes by TCCs shows 3 major patterns. tTG treatment is required for T-cell recognition of the GLU epitopes GLT-17(46-60) by TCC NV17, GLT-56(40-59) by TCC MS156, and GLIA-α20(93-106) by TCC JB20. Equal or enhanced responses after specific deamidation by tTG are found for epitopes GLIA-γ30(222-236) (TCC SV30), and GLU-5 (TCC JP437 and NP27). In the third pattern, the T-cell reaction against the GLU-21 epitope by TCC SV21 is blocked by deamidation of the peptide. Gastroenterology 2002 122, 1729-1737DOI: (10.1053/gast.2002.33606) Copyright © 2002 American Gastroenterological Association Terms and Conditions

Fig. 5 Responses of 2 TCCs against homologue peptides. Response of TCCs TCC NV17 (hatched symbols) and TCC MS156 (closed symbols) to GLT/GLIA homologue peptides. TCC NV17 responds to all peptides except peptide 15, whereas TCC MS156 does not recognize peptides 12, 13, and 15. All peptides are GLT-derived sequences, whereas peptides 11 and 14 also match with GLIA sequences. Gastroenterology 2002 122, 1729-1737DOI: (10.1053/gast.2002.33606) Copyright © 2002 American Gastroenterological Association Terms and Conditions

Fig. 6 Overview of the T-cell responses against the known DQ2 epitopes. TCCs and lines of young and adult patients were tested against the DQ2 epitopes characterized in the present study and the previously published epitopes Glia-α2(62-75) PQPQLPYPQPQLPY, Glia-α9(57-68) QLQPFPQPQLPY, and Glia-γ1 (138-153) QPQQPQQSFPQQQRPF.13,15 The black boxes represent stimulation of the T cells by the epitope. The effect of deamidation of the epitope on the T-cell response is indicated in the individual boxes. tTG indicates requirement of deamidation for recognition, and no tTG indicates blocking of the response by deamidation of the peptide. The remaining responses are (largely) indifferent to deamidation. Gastroenterology 2002 122, 1729-1737DOI: (10.1053/gast.2002.33606) Copyright © 2002 American Gastroenterological Association Terms and Conditions